Home/Filings/4/0001470831-26-000051
4//SEC Filing

Bialecki Andrew 4

Accession 0001470831-26-000051

CIK 0001835830other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 4:29 PM ET

Size

18.1 KB

Accession

0001470831-26-000051

Research Summary

AI-generated summary of this filing

Updated

Klaviyo (KVYO) CEO Andrew Bialecki Sells 167,926 Shares

What Happened

  • Andrew Bialecki, CEO of Klaviyo (KVYO), converted 167,926 shares of Series B common into Series A common and immediately sold those 167,926 shares in open‑market transactions on January 20, 2026. The sales generated total proceeds of about $4,056,400 (167,130 shares at a weighted average $24.16 = $4,037,861; 796 shares at a weighted average $23.29 = $18,539). The conversion itself was recorded as a derivative conversion with no cash consideration.

Key Details

  • Transaction date: January 20, 2026; Form 4 filed January 22, 2026 (appears timely).
  • Sales: 167,130 shares sold at a weighted avg $24.16 (prices ranged $23.48–$24.46); 796 shares sold at a weighted avg $23.29 (prices ranged $23.15–$23.46).
  • Total proceeds: approximately $4,056,400.
  • Conversion: 167,926 Series B shares converted into Series A (coded as derivative conversion, $0 cash consideration).
  • Plan: Transactions were effected pursuant to a Rule 10b5‑1 trading plan adopted May 20, 2025 (footnote F1).
  • Trust holdings: Filing notes shares held in several 2023 trusts (F5–F7) for which Bialecki or family members serve as trustees; he disclaims beneficial ownership except to the extent of any pecuniary interest.
  • Filing notes: weighted‑average price disclosures include ranges and the filer offers to provide per‑price quantities on request (F3, F4).

Context

  • This was a sale of shares (not a purchase), and the filing indicates the trades were made under a pre‑arranged 10b5‑1 plan—often used to avoid timing issues around insider information. The conversion from Series B to Series A is a routine corporate mechanics step (1:1 convertible per the charter) followed by immediate sale; the conversion shows no cash received. The filing does not specify Bialecki’s remaining beneficial ownership after these transactions.

Insider Transaction Report

Form 4
Period: 2026-01-20
Bialecki Andrew
DirectorCo-Chief Executive Officer10% Owner
Transactions
  • Conversion

    Series A Common Stock

    [F1][F2]
    2026-01-20+167,926167,926 total
  • Sale

    Series A Common Stock

    [F1][F3]
    2026-01-20$24.16/sh167,130$4,037,861796 total
  • Sale

    Series A Common Stock

    [F1][F4]
    2026-01-20$23.29/sh796$18,5390 total
  • Conversion

    Series B Common Stock

    [F2][F1]
    2026-01-20167,92669,106,164 total
    Series A Common Stock (167,926 underlying)
Holdings
  • Series B Common Stock

    [F2][F5]
    (indirect: By Trust)
    Series A Common Stock (7,517,410 underlying)
    7,517,410
  • Series B Common Stock

    [F2][F6]
    (indirect: By Trust)
    Series A Common Stock (517,006 underlying)
    517,006
  • Series B Common Stock

    [F2][F7]
    (indirect: By Trust)
    Series A Common Stock (517,006 underlying)
    517,006
  • Series B Common Stock

    [F2]
    (indirect: By Spouse)
    Series A Common Stock (43,218 underlying)
    43,218
Footnotes (7)
  • [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025.
  • [F2]Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.48 to $24.46 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.15 to $23.46 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]Shares held by the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2023, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
  • [F6]Shares held by the Elizabeth L. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person serves as a trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
  • [F7]Shares held by the Andrew P. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Signature
/s/ Landon Edmond, Attorney-in-Fact|2026-01-22

Issuer

Klaviyo, Inc.

CIK 0001835830

Entity typeother

Related Parties

1
  • filerCIK 0001991099

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:29 PM ET
Size
18.1 KB